NOTICE
ANSM - Last updated: 23/12/2015
Name of the medicinal product
CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application
Salicylic acid
framed
Read this leaflet carefully before you start using this medicine. It contains important information for your treatment.
If you have any further questions, ask your doctor or pharmacist.
· Keep this leaflet, you may need to read it again.
· If you need more information and advice, ask your pharmacist.
· If symptoms worsen or persist, consult a physician.
· If you notice any side effects not listed in this leaflet, or if you experience any of the effects listed as serious, please tell your doctor or pharmacist.
Review summary
In this notice :
1. WHAT CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application AND IN WHAT CASES IS IT USED?
2. BEFORE YOU USE CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application?
3. HOW TO USE CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application?
4. WHAT ARE POSSIBLE SIDE EFFECTS?
5. HOW TO STORE CORICIDE THE DEVIL 12.5 g / 100 g, solution for local application?
6. ADDITIONAL INFORMATION
1. WHAT CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application AND IN WHAT CASES IS IT USED?
Pharmacotherapeutic group
keratolytic
(Dermatology)
Therapeutic indications
This medication is recommended in the local topical treatment of corns, calluses, partridge eye and warts.
2. BEFORE YOU USE CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application?
List of information needed before taking the medication
Not applicable.
Cons-indications
Never use CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application in the following cases:
· Allergy to one of the components of the product
· Infected horns
Precautions for use; special warnings
Take care with CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application :
Special warnings
In case of arteritis, diabetes or neuropathy, consult your doctor before using this medication.
Due to the risk of systemic passage, this product should not be applied over a large area.
Precautions for use
If you have failed to take the medication properly, or in the event of a recurrence, consult your doctor. It may be useful to look for the cause and treat it accordingly, (orthopedic measures of correction of the support, modification of the footing).
Do not use on mucous membranes.
Do not overflow on healthy skin.
Interaction with other medicines
Taking or using other medicines:
TO AVOID POSSIBLE INTERACTIONS BETWEEN SEVERAL MEDICINAL PRODUCTS, IT MUST BE INFORMED SYSTEMATICALLY OF ANY OTHER TREATMENT IN PROGRESS AT YOUR DOCTOR OR YOUR PHARMACIST.
Interactions with food and beverages
Not applicable.
Interactions with Herbal Medicines or Alternative Therapies
Not applicable.
Use during pregnancy and lactation
Pregnancy and breast feeding :
This medication should be used with caution during pregnancy and lactation. In general, you should seek advice from your doctor or pharmacist before taking any medication.
Sport
Not applicable.
Effects on ability to drive or use machines
Not applicable.
List of excipients with known effect
Not applicable.
3. HOW TO USE CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application?
Instructions for proper use
Not applicable.
Dosage, Mode and / or route (s) of administration, Frequency of administration and Duration of treatment
Dosage
Apply every morning using the spatula, taking care not to overflow the healthy skin; possibly, protect the healthy skin by means of a dressing (washer).
Let dry. After one week of treatment, remove the mortified tissue after taking a warm foot bath.
In case of wart, a longer treatment may be necessary.
Method and route of administration
Dermal
Symptoms and Instructions for Overdose
If you used more CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application you should:
Risk of burns in case of overdose.
Instructions for omission of one or more doses
Not applicable.
Risk of withdrawal syndrome
Not applicable.
4. WHAT ARE POSSIBLE SIDE EFFECTS?
Description of adverse reactions
Like all drugs, CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application is likely to have undesirable effects, although not everyone is subject to it.
- Skin irritation when applied to healthy skin.
- Risk of local irritation and burning sensation.
If you notice any side effects not listed in this leaflet, or if any of the side effects gets serious, contact your doctor or pharmacist.
5. HOW TO STORE CORICIDE THE DEVIL 12.5 g / 100 g, solution for local application?
Keep this medicine out of the reach and sight of children.
Expiration date
Do not use CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application after the expiry date stated on the outer packaging and bottle after {EXP}.
The expiry date refers to the last day of that month.
Storage conditions
Close the bottle after use.
Flammable product, to be kept away from any source of heat.
If necessary, warnings against visible signs of deterioration
Do not dispose of any medication (including administration devices) into drains or household garbage. Ask your pharmacist to remove any medications you are no longer using. These measures will help protect the environment.
6. ADDITIONAL INFORMATION
Full list of active substances and excipients
What does CORICIDE THE DEVICE contain 12,5 g / 100 g, solution for local application?
The active substance is :
Salicylic acid ................................................ .................................................. 12.50 g
For 100 g of solution for local application.
The other components are :
acetic acid, collodion, ether, castor oil.
Pharmaceutical form and content
What is CORICIDE THE DEVICE 12.5 g / 100 g, solution for local application and contents of the outer packaging?
This medication is in the form of a solution for local application, a 4 g bottle. 8.5 ml Type III brown glass bottle filled to 4 g, closed with a white high density polyethylene stopper with a teflon seal with a tamper-evident ring. A low density polyethylene spatula is provided to allow application of the product.
Only the delivery device provided should be used for this medication.
Name and address of the marketing authorization holder and the holder of the manufacturing authorization responsible for the release of the lots, if different
Holder
SODIA laboratories
Avenue Robert Schuman
51100 Reims
exploiting
SODIA laboratories
Avenue Robert Schuman
51100 Reims
Maker
SODIA laboratories
Avenue Robert Schuman
51100 Reims
Names of the medicinal product in the Member States of the European Economic Area
Not applicable.
Date of approval of the notice
The last date on which this leaflet was approved is {date}.
AMM under exceptional circumstances
Not applicable.
Internet Information
Detailed information on this medicine is available on the Ansm website (France).
Information for health professionals only
Not applicable.
Other